Primarily, we systematically integrated the genomic and clinical data of HNSCC patients (Figure 1) and found neuronal acetylcholine receptor subunit beta-4 (CHRNB4), a kind of nAChR, whose gene expression was upregulated and associated with adverse prognosis in smoking patients. Here, CHRNB4 is linked to head and neck squamous cell carcinoma.